Q2 2024 Holdings
Filed 2024-08-09 | 15 holdings | $949.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Dyne Therapeutics, Inc.(DYN) | Common Stock | 26818M108 | $283.0M | 8,020,136 | 29.8% |
| Kymera Therapeutics, Inc.(KYMR) | Common Stock | 501575104 | $159.7M | 5,350,422 | 16.8% |
| Third Harmonic Bio, Inc.(THRD) | Common Stock | 88427A107 | $141.8M | 10,907,859 | 14.9% |
| Disc Medicine, Inc.(IRON) | Common Stock | 254604101 | $113.1M | 2,509,456 | 11.9% |
| Day One Biopharmaceuticals, Inc.(DAWN) | Common Stock | 23954D109 | $88.6M | 6,430,257 | 9.3% |
| Korro Bio, Inc.(KRRO) | Common Stock | 500946108 | $38.5M | 1,137,149 | 4.1% |
| Q32 Bio, Inc.(QTTB) | Common Stock | 746964105 | $37.6M | 2,092,106 | 4.0% |
| Generation Bio, Co.(GBIOGBX) | Common Stock | 37148K100 | $23.3M | 8,279,484 | 2.5% |
| Vigil Neuroscience, Inc.(VIGL) | Common Stock | 92673K108 | $23.3M | 5,836,874 | 2.5% |
| Replimune Group, Inc.(REPL) | Common Stock | 76029N106 | $18.9M | 2,098,300 | 2.0% |
| Ikena Oncology, Inc. | Common Stock | 45175G108 | $8.3M | 5,018,178 | 0.9% |
| Tectonic Therapeutics, Inc.(TECX) | Common Stock | 878972108 | $6.2M | 378,447 | 0.7% |
| Dianthus Therapeutics, Inc.(DNTH) | Common Stock | 252828108 | $3.5M | 136,979 | 0.4% |
| Aerovate Therapeutics, Inc. | Common Stock | 008064107 | $3.0M | 1,799,232 | 0.3% |
| Spero Therapeutics, Inc.(SPRO) | Common Stock | 84833T103 | $695.9K | 535,336 | 0.1% |